Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
作者信息
Gillessen Silke, de Bono Johann S, Sartor Oliver, Omlin Aurelius Gabriel
机构信息
Department Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Department of Oncology, University of Bern, Bern, Switzerland.
The Institute of Cancer Research/ Royal Marsden, Sutton, UK.
出版信息
Eur Urol. 2018 Feb;73(2):e32-e33. doi: 10.1016/j.eururo.2017.08.014. Epub 2017 Aug 30.
PMID:28869069
Abstract
摘要
相似文献
1
Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
Eur Urol. 2018 Feb;73(2):e32-e33. doi: 10.1016/j.eururo.2017.08.014. Epub 2017 Aug 30.
2
Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
Eur Urol. 2018 Feb;73(2):e31. doi: 10.1016/j.eururo.2017.08.010. Epub 2017 Aug 30.
3
Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508-47 https://doi.org/10.1016/j.eururo.2020.01.012.
Eur Urol. 2020 Nov;78(5):e201-e202. doi: 10.1016/j.eururo.2020.03.012. Epub 2020 Mar 25.
4
Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11.
Eur Urol. 2022 Jul;82(1):e13. doi: 10.1016/j.eururo.2022.03.029. Epub 2022 Mar 28.
5
Re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11.
Eur Urol. 2022 Jul;82(1):e14. doi: 10.1016/j.eururo.2022.03.030. Epub 2022 Mar 28.
6
Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al.
Ann Oncol. 2015 Nov;26(11):2354-5. doi: 10.1093/annonc/mdv360. Epub 2015 Sep 7.
7
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93.
Eur Urol. 2020 Mar;77(3):e67-e68. doi: 10.1016/j.eururo.2019.06.026. Epub 2019 Jul 9.
8
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93.
Eur Urol. 2020 Mar;77(3):e69. doi: 10.1016/j.eururo.2019.05.030. Epub 2019 May 29.
9
Re: Jean-Pierre Droz, Gilles Albrand, Silke Gillessen, et al. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.12.025: Health Assessment of the Elderly is a "Relatively Young" Issue.
Eur Urol. 2017 May;71(5):e150-e151. doi: 10.1016/j.eururo.2017.01.050. Epub 2017 Feb 16.
10
Reply to Ethan B. Ludmir, Zachary R. McCaw, and Lee-Jen Wei's Letter to the Editor re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032. Interpreting the Effect of Ipilimumab following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.
Eur Urol. 2021 Jan;79(1):e12-e13. doi: 10.1016/j.eururo.2020.10.012. Epub 2020 Oct 26.
引用本文的文献
1
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond.
Endocr Relat Cancer. 2018 Oct 31;26(1):R31-R52. doi: 10.1530/ERC-18-0289.
2
[Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].
Urologe A. 2018 Jul;57(7):813-820. doi: 10.1007/s00120-018-0680-9.
3
Third-line treatment and Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):496-508. doi: 10.1007/s00259-017-3895-x. Epub 2017 Dec 16.
Zotero 插件